Identification of Susceptibility SNPs in CTLA-4 and PTPN22 for Scleritis in Han Chinese

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2019 Mar 29

PMID 30921471

Citations 4

Authors

F Li

X Ma

L Du

L Shi

Q Cao

N Li

T Pang

Y Liu

A Kijlstra

P Yang

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to determine the association between 13 single nucleotide polymorphisms (SNPs) in the cytotoxic T lymphocyte-associated antigen-4 (CTLA4) and protein tyrosine phosphatase non-receptor type 22 (PTPN22) genes with scleritis in a Chinese Han population. We recruited 432 scleritis patients and 710 healthy controls. Four tag SNPs of CTLA4 and nine tag SNPs of PTPN22 were selected using Haploview. Genotyping was performed with the Sequenom MassArray® iPLEX GOLD Assay. Genotype and allele frequency differences were analyzed by χ test and Bonferroni correction. Haplotype analysis was performed to further evaluate the association of these two genes with scleritis. In this study, CTLA4/rs3087243 G allele frequency and GG genotype frequency were significantly increased in scleritis patients compared to healthy controls [corrected P-value (Pc) = 0·02, odds ratio (OR) = 1·475, 95% confidence interval (CI) = 1·175-1·851; Pc = 0·04, OR = 1·546, 95% CI = 1·190-2·008, respectively]. None of the tested SNPs in the PTPN22 gene showed an association with scleritis. Haplotype analysis revealed a lower frequency of a CTLA4 TCAA haplotype (order of SNPs: rs733618, rs5742909, rs231775, rs3087243) (Pc = 4·26 × 10 , OR = 0·618, 95% CI = 0·540-0·858) and a higher frequency of a PTPN22 TTATACGCG haplotype (order of SNPs: rs3789604, rs150426536, rs1746853, rs1217403, rs1217406, rs3789609, rs1217414, rs3789612, rs2488457) (Pc = 2·83 × 10 , OR = 1·457, 95% CI = 1·210-1·754) in scleritis patients when compared to healthy controls. In conclusion, our findings indicate that CTLA4 and PTPN22 might confer genetic susceptibility to scleritis in a Chinese Han population.

Citing Articles

The causal impact of genetically predicted inflammatory bowel disease on extraintestinal manifestations: a mendelian randomization study.

Fan X, He A, Li K, Zhang M, Zhang Q, Xiao W BMC Gastroenterol. 2025; 25(1):135.

PMID: 40038580 PMC: 11881308. DOI: 10.1186/s12876-024-03566-4.

Association Study of Anticitrullinated Peptide Antibody Status with Clinical Manifestations and SNPs in Patients Affected with Rheumatoid Arthritis: A Pilot Study.

Issilbayeva A, Ainabekova B, Zhetkenev S, Meiramova A, Akhmetova Z, Karina K Dis Markers. 2022; 2022:2744762.

PMID: 35601739 PMC: 9118096. DOI: 10.1155/2022/2744762.

Polymorphisms and Circulating Plasma Protein Levels of Immune Checkpoints (CTLA-4 and PD-1) Are Associated With Posner-Schlossman Syndrome in Southern Chinese.

Huang X, Liu X, Ye Y, Zhang T, Mei S, Zhu T Front Immunol. 2021; 12:607966.

PMID: 33717091 PMC: 7943469. DOI: 10.3389/fimmu.2021.607966.

The haplotypes of various TNF related genes associated with scleritis in Chinese Han.

Gao Y, Du L, Li F, Ding J, Li G, Cao Q Hum Genomics. 2020; 14(1):46.

PMID: 33287909 PMC: 7720609. DOI: 10.1186/s40246-020-00296-y.

Impact of Single-Nucleotide Polymorphisms of , and on the Effectiveness of Abatacept in Patients with Rheumatoid Arthritis.

Marquez Pete N, Maldonado Montoro M, Perez Ramirez C, Martin A, Martinez de la Plata J, Martinez Martinez F J Pers Med. 2020; 10(4).

PMID: 33187286 PMC: 7711575. DOI: 10.3390/jpm10040220.

References

Magistrelli G, Jeannin P, Herbault N, Benoit De Coignac A, Gauchat J, Bonnefoy J . A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol. 1999; 29(11):3596-602. DOI: 10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y. View

Bouqbis L, Izaabel H, Akhayat O, Perez-Lezaun A, Calafell F, Bertranpetit J . Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population. Genes Immun. 2003; 4(2):132-7. DOI: 10.1038/sj.gene.6363933. View

Watson P, Hayreh S . Scleritis and episcleritis. Br J Ophthalmol. 1976; 60(3):163-91. PMC: 1042706. DOI: 10.1136/bjo.60.3.163. View

Ueda H, Howson J, Esposito L, Heward J, Snook H, Chamberlain G . Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003; 423(6939):506-11. DOI: 10.1038/nature01621. View

Akpek E, Thorne J, Qazi F, Do D, Jabs D . Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004; 111(3):501-6. DOI: 10.1016/j.ophtha.2003.06.006. View

Watson P, Young R . Scleral structure, organisation and disease. A review. Exp Eye Res. 2004; 78(3):609-23. DOI: 10.1016/s0014-4835(03)00212-4. View

Jago C, Yates J, Camara N, Lechler R, Lombardi G . Differential expression of CTLA-4 among T cell subsets. Clin Exp Immunol. 2004; 136(3):463-71. PMC: 1809051. DOI: 10.1111/j.1365-2249.2004.02478.x. View

Torres B, Aguilar F, Franco E, Sanchez E, Sanchez-Roman J, Jimenez Alonso J . Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus. Arthritis Rheum. 2004; 50(7):2211-5. DOI: 10.1002/art.20347. View

Anjos S, Tessier M, Polychronakos C . Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block. J Clin Endocrinol Metab. 2004; 89(12):6257-65. DOI: 10.1210/jc.2004-0881. View

10.

Gough S, Walker L, Sansom D . CTLA4 gene polymorphism and autoimmunity. Immunol Rev. 2005; 204:102-15. DOI: 10.1111/j.0105-2896.2005.00249.x. View

11.

Seldin M, Shigeta R, Laiho K, Li H, Saila H, Savolainen A . Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis. Genes Immun. 2005; 6(8):720-2. DOI: 10.1038/sj.gene.6364255. View

12.

Heward J, Brand O, Barrett J, Carr-Smith J, Franklyn J, Gough S . Association of PTPN22 haplotypes with Graves' disease. J Clin Endocrinol Metab. 2006; 92(2):685-90. DOI: 10.1210/jc.2006-2064. View

13.

Hinks A, Eyre S, Barton A, Thomson W, Worthington J . Investigation of genetic variation across the protein tyrosine phosphatase gene in patients with rheumatoid arthritis in the UK. Ann Rheum Dis. 2006; 66(5):683-6. PMC: 1954621. DOI: 10.1136/ard.2006.060459. View

14.

Du L, Yang P, Hou S, Lin X, Zhou H, Huang X . Association of the CTLA-4 gene with Vogt-Koyanagi-Harada syndrome. Clin Immunol. 2008; 127(1):43-8. DOI: 10.1016/j.clim.2008.01.004. View

15.

Fong L, Sainz de la Maza M, Rice B, Kupferman A, Foster C . Immunopathology of scleritis. Ophthalmology. 1991; 98(4):472-9. DOI: 10.1016/s0161-6420(91)32280-2. View

16.

Umemura T, Ota M, Hamano H, Katsuyama Y, Muraki T, Arakura N . Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol. 2008; 103(3):588-94. DOI: 10.1111/j.1572-0241.2007.01750.x. View

17.

Ichimura M, Kaku H, Fukutani T, Koga H, Mukai T, Miyake I . Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population. Thyroid. 2008; 18(6):625-30. DOI: 10.1089/thy.2007.0353. View

18.

Walker E, Hirschfield G, Xu C, Lu Y, Liu X, Lu Y . CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population. Arthritis Rheum. 2009; 60(4):931-7. DOI: 10.1002/art.24412. View

19.

Gu L, Zhu W, Zhao S, Zhao L, Zhang M, Cui B . Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease. Clin Endocrinol (Oxf). 2009; 72(2):248-55. DOI: 10.1111/j.1365-2265.2009.03617.x. View

20.

Repnik K, Potocnik U . CTLA4 CT60 single-nucleotide polymorphism is associated with Slovenian inflammatory bowel disease patients and regulates expression of CTLA4 isoforms. DNA Cell Biol. 2010; 29(10):603-10. DOI: 10.1089/dna.2010.1021. View